Cream shows promise in fighting skin cancer before it starts
NCT ID NCT02636569
Summary
This study tested whether applying a topical medication called diclofenac could reduce certain markers in the skin linked to the development of non-melanoma skin cancers. It involved 24 adults with a history of these skin cancers and pre-cancerous spots. The goal was to find the best dose to lower these risk markers, potentially guiding future prevention strategies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MELANOMA SKIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham Whitaker Clinic
Birmingham, Alabama, 35233, United States
Conditions
Explore the condition pages connected to this study.